9-127843133-GG-TT
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 4P and 8B. PM1PM2BP6_Very_Strong
The NM_001114753.3(ENG):c.179_180delinsAA(p.Ala60Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A60D) has been classified as Benign.
Frequency
Genomes: not found (cov: 30)
Consequence
ENG
NM_001114753.3 missense
NM_001114753.3 missense
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.05
Genes affected
ENG (HGNC:3349): (endoglin) This gene encodes a homodimeric transmembrane protein which is a major glycoprotein of the vascular endothelium. This protein is a component of the transforming growth factor beta receptor complex and it binds to the beta1 and beta3 peptides with high affinity. Mutations in this gene cause hereditary hemorrhagic telangiectasia, also known as Osler-Rendu-Weber syndrome 1, an autosomal dominant multisystemic vascular dysplasia. This gene may also be involved in preeclampsia and several types of cancer. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 7 uncertain in NM_001114753.3
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 9-127843133-GG-TT is Benign according to our data. Variant chr9-127843133-GG-TT is described in ClinVar as [Likely_benign]. Clinvar id is 414311.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ENG | NM_001114753.3 | c.179_180delinsAA | p.Ala60Glu | missense_variant | 2/15 | ENST00000373203.9 | |
ENG | NM_000118.4 | c.179_180delinsAA | p.Ala60Glu | missense_variant | 2/14 | ||
ENG | NM_001406715.1 | c.179_180delinsAA | p.Ala60Glu | missense_variant | 2/8 | ||
ENG | NM_001278138.2 | c.-368_-367delinsAA | 5_prime_UTR_variant | 2/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ENG | ENST00000373203.9 | c.179_180delinsAA | p.Ala60Glu | missense_variant | 2/15 | 1 | NM_001114753.3 | P2 | |
ENG | ENST00000344849.4 | c.179_180delinsAA | p.Ala60Glu | missense_variant | 2/14 | 1 | A2 | ||
ENG | ENST00000480266.6 | c.-368_-367delinsAA | 5_prime_UTR_variant | 2/15 | 2 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD3 genomes
Cov.:
30
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 30
GnomAD4 genome
Cov.:
30
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 22, 2019 | See Variant Classification Assertion Criteria. - |
Hereditary hemorrhagic telangiectasia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 10, 2023 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 19, 2022 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at